# CMR Surgical Versius: Price, Availability & Status (2026)

CMR Surgical's Versius is a modular soft-tissue surgical robot, US-FDA-cleared for cholecystectomy (De Novo 2024) and commercial across Europe/LatAm/AMEA/Australia. No consumer price.

## Price

_No verified price on record._

There is no consumer price. Versius is enterprise B2B surgical equipment sold to hospitals on per-system contracts, so DEPLOY records zero price points rather than a consumer figure.

## Availability

_Status: internal-only_

Versius is sold to hospitals, not consumers. From UK-based CMR Surgical, it is CE-marked and commercial across Europe, Latin America, AMEA, and Australia, and US-FDA-cleared for cholecystectomy (De Novo, October 2024; Versius Plus 510(k), December 2025).

## Status

CMR Surgical's Versius (and Versius Plus) is a modular, multi-arm, soft-tissue minimal-access surgical robot and the international-soft-tissue archetype of DEPLOY's surgical cluster. Its modular multi-arm architecture is a deliberate contrast to the monolithic design of Intuitive's da Vinci: it is teleoperated and software-driven, capturing telematic, video, and outcome data. On regulatory status: Versius is US-FDA-cleared for cholecystectomy via a De Novo authorization in October 2024, with Versius Plus cleared via 510(k) on December 18, 2025, and a gynecology 510(k) submitted April 29, 2026 (pending). It is not broadly 'US-pending'; only the gynecology indication is.

**Verified deployments:**

- [Distalmotion Dexter (soft-tissue surgical, registry profile)](https://registry.deploy.report/models/distalmotion-dexter)
- [Asensus Senhance (soft-tissue surgical, registry profile)](https://registry.deploy.report/models/asensus-senhance)

## Compare

| Model | Pricing | Tier |
| --- | --- | --- |
| [Moon Surgical Maestro](/price/moon-maestro) | No consumer price | absence (Assistive laparoscopy) |
| [Intuitive da Vinci](/price/intuitive-da-vinci) | No consumer price | absence (Production (verified-at-scale)) |
| [Medtronic Hugo](/price/medtronic-hugo) | No consumer price | absence (Commercial (verified-but-opaque)) |
| [J&J Ottava](/price/jnj-ottava) | No consumer price | absence (Pre-market research) |

## Common questions

### Can I buy a Versius?

No. It is enterprise B2B surgical equipment sold to hospitals on per-system contracts; there is no consumer price.

### Is the Versius FDA-cleared in the US?

Yes, for cholecystectomy: a De Novo authorization (October 2024) plus a Versius Plus 510(k) (December 2025). A gynecology 510(k) was submitted April 2026 and is pending.

## How DEPLOY verified this

- [How DEPLOY tracks pricing](https://news.deploy.report/methodology/how-we-track-pricing)
- [How DEPLOY verifies deployment status](https://news.deploy.report/methodology/how-we-verify-deployment-status)

## Related reading

- [Deploy News: What is CMR Surgical Versius?](https://news.deploy.report/explainers/what-is-cmr-versius)
- [Deploy News: Surgical robotics](https://news.deploy.report/explainers/surgical-robotics)
- [Deploy News: What is a surgical robot?](https://news.deploy.report/explainers/what-is-a-surgical-robot)

## On the registry

- [Model record](https://registry.deploy.report/models/cmr-versius.md)
- [Manufacturer](https://registry.deploy.report/companies/cmr-surgical.md)

_Canonical: https://deploy.report/price/cmr-versius_